nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapagliflozin—CYP1A1—head and neck cancer	0.593	1	CbGaD
Dapagliflozin—CYP2A6—Fluorouracil—head and neck cancer	0.0797	0.267	CbGbCtD
Dapagliflozin—CYP2D6—Hydroxyurea—head and neck cancer	0.0656	0.22	CbGbCtD
Dapagliflozin—CYP1A2—Fluorouracil—head and neck cancer	0.0304	0.102	CbGbCtD
Dapagliflozin—CYP2C9—Fluorouracil—head and neck cancer	0.0274	0.0919	CbGbCtD
Dapagliflozin—ABCB1—Vinblastine—head and neck cancer	0.0246	0.0826	CbGbCtD
Dapagliflozin—CYP2D6—Vinblastine—head and neck cancer	0.0232	0.0779	CbGbCtD
Dapagliflozin—ABCB1—Docetaxel—head and neck cancer	0.0203	0.0681	CbGbCtD
Dapagliflozin—CYP3A4—Vinblastine—head and neck cancer	0.0148	0.0495	CbGbCtD
Dapagliflozin—CYP3A4—Docetaxel—head and neck cancer	0.0122	0.0408	CbGbCtD
Dapagliflozin—Angina unstable—Docetaxel—head and neck cancer	0.00206	0.0609	CcSEcCtD
Dapagliflozin—Extravasation—Vinblastine—head and neck cancer	0.00126	0.0372	CcSEcCtD
Dapagliflozin—Neoplasm—Vinblastine—head and neck cancer	0.000995	0.0294	CcSEcCtD
Dapagliflozin—Blood urea increased—Hydroxyurea—head and neck cancer	0.000948	0.028	CcSEcCtD
Dapagliflozin—Phlebitis—Vinblastine—head and neck cancer	0.000927	0.0274	CcSEcCtD
Dapagliflozin—Neoplasm—Hydroxyurea—head and neck cancer	0.000907	0.0268	CcSEcCtD
Dapagliflozin—Extravasation—Fluorouracil—head and neck cancer	0.000828	0.0244	CcSEcCtD
Dapagliflozin—Cerebrovascular accident—Vinblastine—head and neck cancer	0.000815	0.0241	CcSEcCtD
Dapagliflozin—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.000683	0.0201	CcSEcCtD
Dapagliflozin—Angina pectoris—Vinblastine—head and neck cancer	0.000673	0.0198	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Vinblastine—head and neck cancer	0.000607	0.0179	CcSEcCtD
Dapagliflozin—Myocardial infarction—Vinblastine—head and neck cancer	0.000603	0.0178	CcSEcCtD
Dapagliflozin—Extravasation—Docetaxel—head and neck cancer	0.000598	0.0176	CcSEcCtD
Dapagliflozin—Dysuria—Hydroxyurea—head and neck cancer	0.000589	0.0174	CcSEcCtD
Dapagliflozin—Infestation NOS—Hydroxyurea—head and neck cancer	0.000561	0.0166	CcSEcCtD
Dapagliflozin—Infestation—Hydroxyurea—head and neck cancer	0.000561	0.0166	CcSEcCtD
Dapagliflozin—Neoplasm—Docetaxel—head and neck cancer	0.000471	0.0139	CcSEcCtD
Dapagliflozin—Nasopharyngitis—Fluorouracil—head and neck cancer	0.000469	0.0138	CcSEcCtD
Dapagliflozin—Angina pectoris—Fluorouracil—head and neck cancer	0.000441	0.013	CcSEcCtD
Dapagliflozin—Phlebitis—Docetaxel—head and neck cancer	0.000439	0.013	CcSEcCtD
Dapagliflozin—Hypertension—Vinblastine—head and neck cancer	0.000415	0.0123	CcSEcCtD
Dapagliflozin—Discomfort—Vinblastine—head and neck cancer	0.000405	0.0119	CcSEcCtD
Dapagliflozin—Infestation NOS—Fluorouracil—head and neck cancer	0.000404	0.0119	CcSEcCtD
Dapagliflozin—Infestation—Fluorouracil—head and neck cancer	0.000404	0.0119	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000398	0.0118	CcSEcCtD
Dapagliflozin—Myocardial infarction—Fluorouracil—head and neck cancer	0.000396	0.0117	CcSEcCtD
Dapagliflozin—Urinary tract infection—Fluorouracil—head and neck cancer	0.000393	0.0116	CcSEcCtD
Dapagliflozin—Hyponatraemia—Docetaxel—head and neck cancer	0.00038	0.0112	CcSEcCtD
Dapagliflozin—Pain in extremity—Docetaxel—head and neck cancer	0.000378	0.0112	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000371	0.0109	CcSEcCtD
Dapagliflozin—Discomfort—Hydroxyurea—head and neck cancer	0.000369	0.0109	CcSEcCtD
Dapagliflozin—Oedema—Hydroxyurea—head and neck cancer	0.000358	0.0106	CcSEcCtD
Dapagliflozin—Infection—Hydroxyurea—head and neck cancer	0.000356	0.0105	CcSEcCtD
Dapagliflozin—Dehydration—Docetaxel—head and neck cancer	0.000352	0.0104	CcSEcCtD
Dapagliflozin—Skin disorder—Hydroxyurea—head and neck cancer	0.000348	0.0103	CcSEcCtD
Dapagliflozin—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000346	0.0102	CcSEcCtD
Dapagliflozin—Nasopharyngitis—Docetaxel—head and neck cancer	0.000338	0.00999	CcSEcCtD
Dapagliflozin—Constipation—Vinblastine—head and neck cancer	0.000336	0.00991	CcSEcCtD
Dapagliflozin—Angina pectoris—Docetaxel—head and neck cancer	0.000319	0.0094	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000309	0.00912	CcSEcCtD
Dapagliflozin—Constipation—Hydroxyurea—head and neck cancer	0.000306	0.00904	CcSEcCtD
Dapagliflozin—Infestation—Docetaxel—head and neck cancer	0.000292	0.00861	CcSEcCtD
Dapagliflozin—Infestation NOS—Docetaxel—head and neck cancer	0.000292	0.00861	CcSEcCtD
Dapagliflozin—Hypersensitivity—Vinblastine—head and neck cancer	0.000289	0.00854	CcSEcCtD
Dapagliflozin—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000288	0.00849	CcSEcCtD
Dapagliflozin—Renal failure—Docetaxel—head and neck cancer	0.000287	0.00846	CcSEcCtD
Dapagliflozin—Myocardial infarction—Docetaxel—head and neck cancer	0.000286	0.00844	CcSEcCtD
Dapagliflozin—Body temperature increased—Hydroxyurea—head and neck cancer	0.000283	0.00835	CcSEcCtD
Dapagliflozin—Discomfort—Fluorouracil—head and neck cancer	0.000266	0.00784	CcSEcCtD
Dapagliflozin—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000264	0.00779	CcSEcCtD
Dapagliflozin—Dizziness—Vinblastine—head and neck cancer	0.00026	0.00766	CcSEcCtD
Dapagliflozin—Urinary tract disorder—Docetaxel—head and neck cancer	0.000259	0.00763	CcSEcCtD
Dapagliflozin—Oedema—Fluorouracil—head and neck cancer	0.000258	0.00761	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000258	0.00761	CcSEcCtD
Dapagliflozin—Connective tissue disorder—Docetaxel—head and neck cancer	0.000257	0.00759	CcSEcCtD
Dapagliflozin—Urethral disorder—Docetaxel—head and neck cancer	0.000257	0.00757	CcSEcCtD
Dapagliflozin—Infection—Fluorouracil—head and neck cancer	0.000256	0.00756	CcSEcCtD
Dapagliflozin—Headache—Vinblastine—head and neck cancer	0.000246	0.00726	CcSEcCtD
Dapagliflozin—Hypotension—Fluorouracil—head and neck cancer	0.000241	0.00711	CcSEcCtD
Dapagliflozin—Dizziness—Hydroxyurea—head and neck cancer	0.000237	0.00699	CcSEcCtD
Dapagliflozin—Nausea—Vinblastine—head and neck cancer	0.000233	0.00688	CcSEcCtD
Dapagliflozin—Malnutrition—Docetaxel—head and neck cancer	0.000228	0.00673	CcSEcCtD
Dapagliflozin—Rash—Hydroxyurea—head and neck cancer	0.000226	0.00666	CcSEcCtD
Dapagliflozin—Dermatitis—Hydroxyurea—head and neck cancer	0.000226	0.00666	CcSEcCtD
Dapagliflozin—Headache—Hydroxyurea—head and neck cancer	0.000224	0.00662	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000223	0.00657	CcSEcCtD
Dapagliflozin—Back pain—Docetaxel—head and neck cancer	0.00022	0.00651	CcSEcCtD
Dapagliflozin—Nausea—Hydroxyurea—head and neck cancer	0.000213	0.00628	CcSEcCtD
Dapagliflozin—Urticaria—Fluorouracil—head and neck cancer	0.000205	0.00604	CcSEcCtD
Dapagliflozin—Body temperature increased—Fluorouracil—head and neck cancer	0.000204	0.00601	CcSEcCtD
Dapagliflozin—Hypertension—Docetaxel—head and neck cancer	0.000197	0.00581	CcSEcCtD
Dapagliflozin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000193	0.00569	CcSEcCtD
Dapagliflozin—Hypersensitivity—Fluorouracil—head and neck cancer	0.00019	0.0056	CcSEcCtD
Dapagliflozin—Anaphylactic shock—Docetaxel—head and neck cancer	0.000186	0.00549	CcSEcCtD
Dapagliflozin—Oedema—Docetaxel—head and neck cancer	0.000186	0.00549	CcSEcCtD
Dapagliflozin—Infection—Docetaxel—head and neck cancer	0.000185	0.00545	CcSEcCtD
Dapagliflozin—Skin disorder—Docetaxel—head and neck cancer	0.000181	0.00533	CcSEcCtD
Dapagliflozin—Hypotension—Docetaxel—head and neck cancer	0.000174	0.00513	CcSEcCtD
Dapagliflozin—Dizziness—Fluorouracil—head and neck cancer	0.00017	0.00503	CcSEcCtD
Dapagliflozin—Rash—Fluorouracil—head and neck cancer	0.000163	0.0048	CcSEcCtD
Dapagliflozin—Dermatitis—Fluorouracil—head and neck cancer	0.000162	0.00479	CcSEcCtD
Dapagliflozin—Headache—Fluorouracil—head and neck cancer	0.000161	0.00476	CcSEcCtD
Dapagliflozin—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000161	0.00474	CcSEcCtD
Dapagliflozin—Constipation—Docetaxel—head and neck cancer	0.000159	0.00469	CcSEcCtD
Dapagliflozin—Nausea—Fluorouracil—head and neck cancer	0.000153	0.00452	CcSEcCtD
Dapagliflozin—Body temperature increased—Docetaxel—head and neck cancer	0.000147	0.00434	CcSEcCtD
Dapagliflozin—Hypersensitivity—Docetaxel—head and neck cancer	0.000137	0.00404	CcSEcCtD
Dapagliflozin—Dizziness—Docetaxel—head and neck cancer	0.000123	0.00363	CcSEcCtD
Dapagliflozin—Rash—Docetaxel—head and neck cancer	0.000117	0.00346	CcSEcCtD
Dapagliflozin—Dermatitis—Docetaxel—head and neck cancer	0.000117	0.00346	CcSEcCtD
Dapagliflozin—Headache—Docetaxel—head and neck cancer	0.000117	0.00344	CcSEcCtD
Dapagliflozin—SLC5A4—Metabolism—GPX1—head and neck cancer	0.000115	0.00153	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—CYP1A1—head and neck cancer	0.000114	0.00151	CbGpPWpGaD
Dapagliflozin—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.000113	0.0015	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000111	0.00148	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000111	0.00148	CbGpPWpGaD
Dapagliflozin—CYP2A6—Biological oxidations—CYP1A1—head and neck cancer	0.000111	0.00148	CbGpPWpGaD
Dapagliflozin—Nausea—Docetaxel—head and neck cancer	0.00011	0.00326	CcSEcCtD
Dapagliflozin—SLC5A4—Disease—NOTCH1—head and neck cancer	0.000109	0.00145	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000108	0.00144	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.0001	0.00133	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.0001	0.00133	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.0001	0.00133	CbGpPWpGaD
Dapagliflozin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	9.92e-05	0.00132	CbGpPWpGaD
Dapagliflozin—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	9.85e-05	0.00131	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	9.82e-05	0.00131	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—UROD—head and neck cancer	9.76e-05	0.0013	CbGpPWpGaD
Dapagliflozin—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	9.5e-05	0.00126	CbGpPWpGaD
Dapagliflozin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	9.44e-05	0.00126	CbGpPWpGaD
Dapagliflozin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	9.32e-05	0.00124	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—TYMS—head and neck cancer	9.19e-05	0.00122	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—TYMS—head and neck cancer	9.19e-05	0.00122	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—GSTM1—head and neck cancer	9.08e-05	0.00121	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—GSTM1—head and neck cancer	9.08e-05	0.00121	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	9e-05	0.0012	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—CASP8—head and neck cancer	8.97e-05	0.00119	CbGpPWpGaD
Dapagliflozin—CYP1A1—Biological oxidations—GSTM1—head and neck cancer	8.72e-05	0.00116	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—GPX1—head and neck cancer	8.7e-05	0.00116	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—GPX1—head and neck cancer	8.7e-05	0.00116	CbGpPWpGaD
Dapagliflozin—CYP3A4—Biological oxidations—NAT2—head and neck cancer	8.69e-05	0.00116	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—CYP1A1—head and neck cancer	8.61e-05	0.00115	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—CYP1A1—head and neck cancer	8.61e-05	0.00115	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metapathway biotransformation—GSTM1—head and neck cancer	8.6e-05	0.00114	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	8.57e-05	0.00114	CbGpPWpGaD
Dapagliflozin—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	8.42e-05	0.00112	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	8.34e-05	0.00111	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—NOTCH1—head and neck cancer	8.24e-05	0.0011	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—NOTCH1—head and neck cancer	8.24e-05	0.0011	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—PTGS2—head and neck cancer	8.07e-05	0.00107	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	8.04e-05	0.00107	CbGpPWpGaD
Dapagliflozin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	7.66e-05	0.00102	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—UROD—head and neck cancer	7.27e-05	0.000968	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—TYMS—head and neck cancer	7.1e-05	0.000945	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	7.09e-05	0.000944	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—PTEN—head and neck cancer	7.04e-05	0.000937	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—GSTM1—head and neck cancer	7.01e-05	0.000934	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—IL2—head and neck cancer	6.78e-05	0.000903	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—PTGS2—head and neck cancer	6.76e-05	0.0009	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—GPX1—head and neck cancer	6.72e-05	0.000894	CbGpPWpGaD
Dapagliflozin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	6.65e-05	0.000886	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—CYP1A1—head and neck cancer	6.65e-05	0.000885	CbGpPWpGaD
Dapagliflozin—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	6.56e-05	0.000874	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	6.51e-05	0.000867	CbGpPWpGaD
Dapagliflozin—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	6.51e-05	0.000866	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	6.48e-05	0.000862	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	6.47e-05	0.000862	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—NAT2—head and neck cancer	6.47e-05	0.000861	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	6.42e-05	0.000854	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	6.38e-05	0.00085	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	6.38e-05	0.000849	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	6.38e-05	0.000849	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—STAT3—head and neck cancer	6.29e-05	0.000838	CbGpPWpGaD
Dapagliflozin—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	6.22e-05	0.000828	CbGpPWpGaD
Dapagliflozin—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	6.17e-05	0.000821	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	6.14e-05	0.000817	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—PTGS2—head and neck cancer	6.12e-05	0.000814	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—PTGS2—head and neck cancer	6.12e-05	0.000814	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	6.08e-05	0.00081	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—MAPK3—head and neck cancer	6.01e-05	0.0008	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—PTEN—head and neck cancer	5.89e-05	0.000785	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—UROD—head and neck cancer	5.81e-05	0.000773	CbGpPWpGaD
Dapagliflozin—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	5.76e-05	0.000767	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—MAPK1—head and neck cancer	5.72e-05	0.000762	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—EGFR—head and neck cancer	5.72e-05	0.000761	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—DPYD—head and neck cancer	5.67e-05	0.000755	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	5.64e-05	0.000751	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.58e-05	0.000743	CbGpPWpGaD
Dapagliflozin—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	5.56e-05	0.00074	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	5.53e-05	0.000736	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	5.48e-05	0.00073	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—UROD—head and neck cancer	5.47e-05	0.000728	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—UROD—head and neck cancer	5.42e-05	0.000722	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—YAP1—head and neck cancer	5.38e-05	0.000716	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—PTEN—head and neck cancer	5.33e-05	0.00071	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—PTEN—head and neck cancer	5.33e-05	0.00071	CbGpPWpGaD
Dapagliflozin—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	5.27e-05	0.000702	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—NAT2—head and neck cancer	5.26e-05	0.0007	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	5.2e-05	0.000692	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	5.12e-05	0.000682	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—PTGS2—head and neck cancer	5.12e-05	0.000682	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—PTGS2—head and neck cancer	5.12e-05	0.000682	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—PIK3CA—head and neck cancer	4.96e-05	0.000661	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—STAT3—head and neck cancer	4.77e-05	0.000635	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—STAT3—head and neck cancer	4.77e-05	0.000635	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—UROD—head and neck cancer	4.64e-05	0.000617	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—DPYD—head and neck cancer	4.61e-05	0.000614	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—HRAS—head and neck cancer	4.59e-05	0.000611	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—MAPK3—head and neck cancer	4.56e-05	0.000607	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—MAPK3—head and neck cancer	4.56e-05	0.000607	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—PTEN—head and neck cancer	4.47e-05	0.000595	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—PTEN—head and neck cancer	4.47e-05	0.000595	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	4.43e-05	0.00059	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—YAP1—head and neck cancer	4.37e-05	0.000582	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—MAPK1—head and neck cancer	4.34e-05	0.000577	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—MAPK1—head and neck cancer	4.34e-05	0.000577	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—EGFR—head and neck cancer	4.34e-05	0.000577	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—EGFR—head and neck cancer	4.34e-05	0.000577	CbGpPWpGaD
Dapagliflozin—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	4.29e-05	0.000571	CbGpPWpGaD
Dapagliflozin—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	4.25e-05	0.000565	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	4.23e-05	0.000563	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.21e-05	0.00056	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—PIK3CA—head and neck cancer	4.16e-05	0.000553	CbGpPWpGaD
Dapagliflozin—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	4.07e-05	0.000541	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—AKT1—head and neck cancer	4.06e-05	0.00054	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—NAT2—head and neck cancer	4.05e-05	0.000539	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	4.01e-05	0.000534	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—PTGS2—head and neck cancer	3.95e-05	0.000526	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	3.8e-05	0.000506	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—PIK3CA—head and neck cancer	3.76e-05	0.000501	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—PIK3CA—head and neck cancer	3.76e-05	0.000501	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	3.61e-05	0.000481	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	3.6e-05	0.000479	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—UROD—head and neck cancer	3.58e-05	0.000476	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—DPYD—head and neck cancer	3.55e-05	0.000473	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—HRAS—head and neck cancer	3.48e-05	0.000463	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—HRAS—head and neck cancer	3.48e-05	0.000463	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—PTEN—head and neck cancer	3.45e-05	0.000459	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—AKT1—head and neck cancer	3.4e-05	0.000452	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—YAP1—head and neck cancer	3.37e-05	0.000449	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.29e-05	0.000437	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	3.26e-05	0.000434	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—TYMS—head and neck cancer	3.23e-05	0.00043	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.21e-05	0.000427	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—GSTM1—head and neck cancer	3.19e-05	0.000425	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—PIK3CA—head and neck cancer	3.15e-05	0.000419	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—PIK3CA—head and neck cancer	3.15e-05	0.000419	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	3.15e-05	0.000419	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—AKT1—head and neck cancer	3.07e-05	0.000409	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—AKT1—head and neck cancer	3.07e-05	0.000409	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—GPX1—head and neck cancer	3.06e-05	0.000407	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—CYP1A1—head and neck cancer	3.03e-05	0.000403	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—NAT2—head and neck cancer	3.02e-05	0.000402	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.87e-05	0.000381	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	2.84e-05	0.000379	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	2.69e-05	0.000358	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—DPYD—head and neck cancer	2.65e-05	0.000352	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—TYMS—head and neck cancer	2.63e-05	0.00035	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—GSTM1—head and neck cancer	2.6e-05	0.000346	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—AKT1—head and neck cancer	2.57e-05	0.000343	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—AKT1—head and neck cancer	2.57e-05	0.000343	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	2.56e-05	0.000341	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	2.56e-05	0.000341	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—YAP1—head and neck cancer	2.51e-05	0.000334	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—GPX1—head and neck cancer	2.49e-05	0.000331	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—CYP1A1—head and neck cancer	2.46e-05	0.000328	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—PIK3CA—head and neck cancer	2.43e-05	0.000324	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—NAT2—head and neck cancer	2.41e-05	0.000321	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.39e-05	0.000318	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.37e-05	0.000315	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—NAT2—head and neck cancer	2.27e-05	0.000302	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—NAT2—head and neck cancer	2.25e-05	0.0003	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	2.22e-05	0.000296	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	2.15e-05	0.000286	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—DPYD—head and neck cancer	2.11e-05	0.000281	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.04e-05	0.000272	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—TYMS—head and neck cancer	2.02e-05	0.000269	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.02e-05	0.000269	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.02e-05	0.000269	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—YAP1—head and neck cancer	2.01e-05	0.000267	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—GSTM1—head and neck cancer	2e-05	0.000266	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—DPYD—head and neck cancer	1.99e-05	0.000265	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—AKT1—head and neck cancer	1.99e-05	0.000265	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—DPYD—head and neck cancer	1.98e-05	0.000263	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—NAT2—head and neck cancer	1.92e-05	0.000256	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—GPX1—head and neck cancer	1.92e-05	0.000255	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—CYP1A1—head and neck cancer	1.9e-05	0.000253	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—YAP1—head and neck cancer	1.89e-05	0.000252	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.89e-05	0.000251	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—YAP1—head and neck cancer	1.87e-05	0.00025	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.81e-05	0.000242	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PTGS2—head and neck cancer	1.8e-05	0.00024	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—DPYD—head and neck cancer	1.69e-05	0.000225	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.65e-05	0.000219	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—YAP1—head and neck cancer	1.6e-05	0.000213	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PTEN—head and neck cancer	1.57e-05	0.000209	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—TYMS—head and neck cancer	1.51e-05	0.000201	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—GSTM1—head and neck cancer	1.49e-05	0.000198	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—NAT2—head and neck cancer	1.49e-05	0.000198	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PTGS2—head and neck cancer	1.46e-05	0.000195	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—GPX1—head and neck cancer	1.43e-05	0.00019	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.41e-05	0.000187	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—DPYD—head and neck cancer	1.3e-05	0.000173	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PTEN—head and neck cancer	1.28e-05	0.00017	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—YAP1—head and neck cancer	1.24e-05	0.000165	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.23e-05	0.000163	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—TYMS—head and neck cancer	1.2e-05	0.00016	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.2e-05	0.00016	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GSTM1—head and neck cancer	1.19e-05	0.000159	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.16e-05	0.000155	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—GPX1—head and neck cancer	1.14e-05	0.000152	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—TYMS—head and neck cancer	1.14e-05	0.000151	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CYP1A1—head and neck cancer	1.13e-05	0.00015	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PTGS2—head and neck cancer	1.13e-05	0.00015	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—TYMS—head and neck cancer	1.13e-05	0.00015	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GSTM1—head and neck cancer	1.12e-05	0.000149	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GSTM1—head and neck cancer	1.11e-05	0.000148	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—PIK3CA—head and neck cancer	1.11e-05	0.000147	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—GPX1—head and neck cancer	1.07e-05	0.000143	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—GPX1—head and neck cancer	1.07e-05	0.000142	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CYP1A1—head and neck cancer	1.06e-05	0.000142	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CYP1A1—head and neck cancer	1.05e-05	0.00014	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.05e-05	0.00014	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PTEN—head and neck cancer	9.84e-06	0.000131	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—TYMS—head and neck cancer	9.62e-06	0.000128	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GSTM1—head and neck cancer	9.51e-06	0.000127	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—GPX1—head and neck cancer	9.1e-06	0.000121	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—AKT1—head and neck cancer	9.05e-06	0.00012	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CYP1A1—head and neck cancer	9.01e-06	0.00012	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—PIK3CA—head and neck cancer	9e-06	0.00012	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.66e-06	0.000115	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PTGS2—head and neck cancer	8.41e-06	0.000112	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—TYMS—head and neck cancer	7.42e-06	9.88e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	7.4e-06	9.86e-05	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—AKT1—head and neck cancer	7.36e-06	9.79e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GSTM1—head and neck cancer	7.34e-06	9.77e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PTEN—head and neck cancer	7.33e-06	9.76e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—GPX1—head and neck cancer	7.03e-06	9.35e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CYP1A1—head and neck cancer	6.96e-06	9.26e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—PIK3CA—head and neck cancer	6.94e-06	9.24e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PTGS2—head and neck cancer	6.71e-06	8.94e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PTGS2—head and neck cancer	6.33e-06	8.42e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PTGS2—head and neck cancer	6.27e-06	8.35e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PTEN—head and neck cancer	5.85e-06	7.79e-05	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—AKT1—head and neck cancer	5.67e-06	7.55e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PTEN—head and neck cancer	5.52e-06	7.34e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PTEN—head and neck cancer	5.47e-06	7.28e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PTGS2—head and neck cancer	5.36e-06	7.13e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—PIK3CA—head and neck cancer	5.17e-06	6.88e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PTEN—head and neck cancer	4.67e-06	6.22e-05	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—AKT1—head and neck cancer	4.22e-06	5.62e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PTGS2—head and neck cancer	4.14e-06	5.51e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—PIK3CA—head and neck cancer	4.13e-06	5.5e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—PIK3CA—head and neck cancer	3.89e-06	5.18e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—PIK3CA—head and neck cancer	3.86e-06	5.14e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PTEN—head and neck cancer	3.61e-06	4.8e-05	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—AKT1—head and neck cancer	3.37e-06	4.49e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—PIK3CA—head and neck cancer	3.3e-06	4.39e-05	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—AKT1—head and neck cancer	3.18e-06	4.23e-05	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—AKT1—head and neck cancer	3.15e-06	4.2e-05	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—AKT1—head and neck cancer	2.69e-06	3.59e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—PIK3CA—head and neck cancer	2.54e-06	3.39e-05	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—AKT1—head and neck cancer	2.08e-06	2.77e-05	CbGpPWpGaD
